Tablet
Generics: Upadacitinib
Brand: Ziska Pharmaceuticals Ltd.
Indications: Upadacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.